Excelsior Medical Co., Ltd. - Laporan Laba Rugi (TTM)

Excelsior Medical Co., Ltd.
TW ˙ TWSE ˙ TW0004104005
NT$ 88.10 ↓ -0.30 (-0.34%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Excelsior Medical Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 6,709 6,675 6,571 6,566 6,456 6,573 6,652 6,746 7,011 7,187 7,485 7,833 8,012 8,233 8,269 8,406 8,445 8,539 8,646 8,654
Change (%) -0.50 -1.56 -0.08 -1.67 1.82 1.20 1.41 3.93 2.50 4.15 4.65 2.28 2.77 0.43 1.66 0.47 1.10 1.26 0.09
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 5,430 5,369 5,272 5,241 5,112 5,199 5,241 5,311 5,536 5,673 5,948 6,239 6,380 6,564 6,594 6,725 6,727 6,757 6,819 6,781
Change (%) -1.13 -1.80 -0.60 -2.45 1.70 0.80 1.34 4.25 2.46 4.86 4.88 2.27 2.88 0.46 1.99 0.03 0.44 0.91 -0.55
% of Revenue 80.94 80.43 80.23 79.82 79.19 79.10 78.78 78.73 78.96 78.93 79.47 79.65 79.64 79.72 79.75 80.01 79.66 79.14 78.87 78.36
Gross Operating Profit 1,279 1,307 1,299 1,325 1,343 1,374 1,411 1,435 1,475 1,514 1,537 1,594 1,631 1,670 1,675 1,681 1,718 1,781 1,827 1,873
Change (%) 2.18 -0.59 1.99 1.41 2.27 2.72 1.68 2.77 2.65 1.48 3.76 2.33 2.35 0.31 0.36 2.21 3.68 2.57 2.49
% of Revenue 19.06 19.57 19.77 20.18 20.81 20.90 21.22 21.27 21.04 21.07 20.53 20.35 20.36 20.28 20.25 19.99 20.34 20.86 21.13 21.64
SG&A 782 777 766 771 761 778 809 840 880 906 922 945 965 973 987 1,001 1,005 1,032 1,062 1,077
Change (%) -0.61 -1.43 0.64 -1.33 2.18 4.00 3.93 4.75 2.96 1.71 2.45 2.20 0.76 1.42 1.45 0.41 2.71 2.90 1.37
% of Revenue 11.66 11.65 11.66 11.75 11.79 11.83 12.16 12.46 12.56 12.61 12.32 12.06 12.05 11.81 11.93 11.91 11.90 12.09 12.28 12.44
R&D 0 0 0 -0 0
Change (%) 193.33 38.64 -193.33
% of Revenue 0.00 0.00 0.00 -0.00 0.00
OpEx 6,215 6,146 6,039 6,015 5,874 5,978 6,050 6,152 6,418 6,580 6,871 7,183 7,342 7,531 7,573 7,716 7,724 7,785 7,877 7,858
Change (%) -1.11 -1.74 -0.40 -2.34 1.77 1.21 1.68 4.31 2.54 4.41 4.55 2.21 2.57 0.57 1.89 0.10 0.79 1.18 -0.24
% of Revenue 92.64 92.07 91.90 91.62 90.99 90.95 90.96 91.20 91.53 91.56 91.79 91.70 91.64 91.46 91.59 91.79 91.46 91.18 91.11 90.80
Operating Income 494 529 532 550 581 595 602 594 594 607 614 650 670 703 696 690 722 753 769 796
Change (%) 7.09 0.56 3.47 5.63 2.33 1.12 -1.28 -0.02 2.15 1.28 5.81 3.06 4.92 -1.03 -0.85 4.61 4.39 2.08 3.48
% of Revenue 7.36 7.93 8.10 8.38 9.01 9.05 9.04 8.80 8.47 8.44 8.21 8.30 8.36 8.54 8.41 8.21 8.54 8.82 8.89 9.20
Interest Expense -22 -7 -6 -5 -6 -4 -4 -6 -4 -6 -7 -7 -7 -14 -16 -18 -19 -19 -22 -25
Change (%) -66.21 -16.27 -15.28 4.36 -33.70 -3.40 71.34 -27.78 35.82 18.24 -6.01 9.03 99.37 12.76 13.43 1.29 0.55 18.83 12.24
% of Revenue -0.33 -0.11 -0.09 -0.08 -0.09 -0.06 -0.05 -0.09 -0.06 -0.08 -0.09 -0.08 -0.09 -0.17 -0.20 -0.22 -0.22 -0.22 -0.26 -0.29
Net Income 545 572 564 555 577 607 644 648 682 667 701 734 716 747 730 777 767 771 781 791
Change (%) 4.95 -1.27 -1.69 4.00 5.22 6.14 0.58 5.21 -2.12 5.08 4.69 -2.49 4.29 -2.23 6.48 -1.26 0.49 1.31 1.21
% of Revenue 8.12 8.56 8.59 8.45 8.94 9.24 9.69 9.61 9.73 9.29 9.37 9.37 8.94 9.07 8.83 9.25 9.09 9.03 9.04 9.14

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista